Using pharmacogenomic testing to personalize antidepressants, anxiolytics, and more
Prescribing psychiatric medications is a complex process that often takes trial and error to find the right medication for each patient. By using pharmacogenomic (PGx) testing, psychiatry providers are uncovering genetic insights about their patients that may help them more quickly identify which medications to avoid and which to try first.
OneOme’s RightMed® test, plus the supporting PSYCHIATRY REPORT and MTHFR REPORT, are helping psychiatry providers identify effective treatments faster, leading to fewer side effects and less trial and error to find the right medication.
The Sample RightMed psychiatry report includes:
Get started today to take control of your health.
The RightMed test gives providers insight into how a patient is predicted to respond to antidepressants, antipsychotics, anxiolytics, ADHD medications, and more. Using information from the RightMed test, psychiatry providers may identify the best place to start with their patients’ medications, cutting down on the time it takes to find an effective treatment.
A comprehensive PGx test that analyzes 27 genes and provides results for 360+ medications
The option to add the MTHFR report as a complimentary add-on
A streamlined PSYCHIATRY REPORT, which features only medications relevant to psychiatry
Access to the RightMed Advisor, an interactive tool that helps make results actionable
Complimentary consults with OneOme’s clinical pharmacists
Traditionally, psychiatry providers have thought to use PGx testing only after treatment has failed for a patient. This is shifting as psychiatry providers recognize the benefit to using PGx results earlier in treatment.
Here are just a few examples of how the RightMed test is being used in psychiatry:
Prior to initiating first antidepressant, tricyclic antidepressant, or an adjunvant psychiatric medication being used for treatment of a mood disorder or substance abuse disorder
After diagnosis of a comorbid psychiatric disorder and opioid use disorder or a comorbid psychiatric disorder and metabolic disorder
After first antidepressant medication therapy failure in patients with major depressive disorder
When patient experiences QTc prolongation effects after being prescribed escitalopram or citalopram
If the patient is taking more than five medications
Download our Guide to the RightMed test for psychiatry for more information about using the test in psychiatry.
“Carly is 17 years old, and for 10 years we struggled to control her anxiety, ADHD, and depression until we found the RightMed test,” Carly’s mom, Sandy, says. “I’m forever grateful and thrilled to know OneOme exists.”
Are you a patient? LEARN HOW TO GET THE RIGHTMED TEST >